CoChat

The case for induced pluripotent stem cell‐derived cardiomyocytes in pharmacological screening

Open access
Khan, Jaffar M, Lyon, Alexander R, Harding, Sian E · 2013 · British Journal of Pharmacology
Cited by 63

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

The current drug screening models are deficient, particularly in detecting cardiac side effects. Human stem cell‐derived cardiomyocytes could aid both early cardiotoxicity detection and novel drug discovery. Work over the last decade has generated human embryonic stem cells as potentially accurate sources of human cardiomyocytes, but ethical constraints and poor efficacy in establishing cell lines limit their use. Induced pluripotent stem cells do not require the use of human embryos and have the added advantage of producing patient‐specific cardiomyocytes, allowing both generic and disease‐ and patient‐specific pharmacological screening, as well as drug development through disease modelling. A critical question is whether sufficient standards have been achieved in the reliable and reproducible generation of ‘adult‐like’ cardiomyocytes from human fibroblast tissue to progress from validation to safe use in practice and drug discovery. This review will highlight the need for a new experimental system, assess the validity of human induced pluripotent stem cell‐derived cardiomyocytes and explore what the future may hold for their use in pharmacology. LINKED ARTICLES This article is part of a themed section on Regenerative Medicine and Pharmacology: A Look to the Future. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2013.169.issue‐2

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.2012.02118.x

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

See all 63

Metadata

Authors
Khan, J. M., Lyon, A. R., & Harding, S. E.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2013-04-25
Volume
169
Issue
2
Pages
304-317
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2168235673
Cited by
63
References
22
FWCI
2.32
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The case for induced pluripotent stem cell‐derived cardiomyocytes in pharmacological screening. https://app.cochat.ai/papers/10.1111/j.1476-5381.2012.02118.x
The paper
Khan, J. M., Lyon, A. R., & Harding, S. E. (2013). The case for induced pluripotent stem cell‐derived cardiomyocytes in pharmacological screening. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2012.02118.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.